Comment
Our belief that the cause of our patient's bilateral 10th nerve palsies was hydralazine induced systemic lupus erythematosus was based on the clinical presentation, antibody state, and subsequent clinical and serological responses to hydralazine withdrawal and steroids.
Hydralazine induced systemic lupus erythematosus usually occurs after six months to two years ofexposure to the drug. The disease is dose related and is uncommon at the dosage that our patient was receiving. '1 Renal disease is unusual and to our knowledge nervous system disease has been limited to isolated cases of peripheral neuritis, retrobulbar neuritis, loss of taste, and paraesthesias.3 Antinuclear factor titres are high, usually with absent anti-doublestranded DNA antibodies and normal concentrations of complement,2 as in our patient. Remission occurs on withdrawal of the drug. Aspirin or other nonsteroidal drugs may be used for musculoskeletal symptoms but more serious manifestations warrant short term treatment with steroids.24 Full recovery is usual, as in our patient, though in her case this was not before serious and rapid complications had developed.
Since reporting this case we have seen a further patient who developed a 10th nerve palsy while receiving hydralazine 50 mg twice daily for two years for hypertension complicating polycystic kidney disease; there was clinical and serological support for the diagnosis of hydralazine related systemic lupus erythematosus. In his case resolution of the palsy did not occur despite withdrawal of hydralazine and he subsequently died from ischaemic heart disease (confirmed at necropsy).
I Cameron HA, Ramsav LE. The lupus syndrome induced by hydralazine: a common complication withlow dose treatment. BrMedJ' 1984; 289:410- We studied 25 patients (24 women, one man; median age 56 (range 41-79)) who were followed up for a minimum of 12 months after treatment of non-toxic goitre with iodine-131. All patients had a multinodular goitre on technetium-99m thyroid scanning, and six had had a thyroidectomy. In all cases this treatment was chosen owing to a high operative risk, previous thyroidectomy, or refusal to be operated on. Informed consent was obtained from all patients. Serum thyroxine, triiodothyronine, and thyrotrophin concentrations, triiodothyronine resin uptake, and the size of the thyroid on ultrasonography were determined before treatment as well as one, two, three, six, and 12 months after treatment.2 Iodine-131 was given at a dose of 3 7 MBq/g total thyroid mass corrected to a 100% uptake of iodine-131 in 24 hours. The median dose was 555 (range 244-1021) MBq. Twenty of 23 patients who received one dose remained euthyroid during the 12 month follow up. Mean thyroid volume (normal range 9-28 ml) decreased gradually from 73-2 (SEM 6-4) ml to 43 2 (5-1) ml at 12 months (figure; p<0001, Wilcoxon's test for paired data). Two patients developed permanent hypothyroidism two and three months after treatment, and one had transient hyperthyroidism lasting 10 months. In this last patient thyroid volume gradually decreased from 49 to 24 ml. Two patients were given two doses of iodine-131 to reduce the size of the thyroid; their thyroid volume decreased from 75 to 40 ml and from 76 to 35 ml, and both remained euthyroid.
Suppressive treatment of diffuse non-toxic goitre with thyroxine or triiodothyronine reduces the thyroid -3 (0 3, 19697 during the six years, eight were rejected because of lack of information. The remaining 108 deaths were examined and the most nctable finding was the contribution of army families to all postperinatal deaths and to deaths due to the sudden infant death syndrome. In all, 14 deaths occurred in families in which the father was a soldier, so that the postperinatal death rate for army babies was 10 2/1000 live births compared with 5 1/1000 live births for all the other babies in the study (X2 test with Yates's correction 5 14; p=002; df= 1) ( NS). The postperinatal death rate for army babies, which was twice the rate for other babies (relative risk=2; standard normal deviate=2-43; p=002; 95% confidence interval 1-14 to 3 50), was therefore due mainly to the sudden infant death syndrome.
The epidemiological characteristics of all the deaths in the review mainly confirmed the patterns described in other studies,' 2 with some exceptions. Army mothers tended to be younger than other mothers (mean age 21 v 26 years; NS), more of them smoked (8 (57-1%) v 40 (42 6%); NS), and fewer intended to breast feed their babies compared with other mothers (5 (35 7%) v 50 (53 2%); NS). Significantly more army families had a history of marital stress or violence, or both (6 (42 9%) v 14 (14-9%); p=005). The obvious constraint of a retrospective study based on examining written records is that data are almost certainly incomplete. Nevertheless, these differences were found.
The higher death rates in army babies compared with all other babies in the district is of concern to us for two reasons. A search of published work failed to identify any previous study examining infant mortality in other garrison towns for comparison with our results. Secondly, the health service input to the garrison, which contributes about 200 births a year, consists of two designated health visitors. We do not know what additional support might help reduce mortality in the army. We speculate that the young age of the mothers, their isolation in the garrison, and the lack of family support-given that Colchester is often not the home town of the soldiers or their wivesprobably all contribute to the higher mortality of these babies.
There were too few cases in this review to provide any concrete explanations for the differences in mortality. A case-control study of deaths since 1984 is being considered to shed light on the prospects for prevention.
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